Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in <i>BRAF</i> <sup> <i>V600E</i> </sup> melanomaSiwen Hu‐Lieskovan, Antoni Ribas|Science Translational Medicine|2015Cited by 566